Can You Inject a GLP-1 Into a Stretch Mark? What the Anatomy Says and the Research Has Not Asked

Two questions, and most pages only answer the easier one

Women ask about GLP-1s and stretch marks in two distinct ways, and they want different things.

The first is does this drug cause stretch marks. The second — and in live search it is the more common one — is my stomach is covered in them, so where am I actually supposed to put the needle.

The second question is the one that has no good published answer anywhere, which is presumably why it keeps getting asked in forums. It is also the one that belongs on a site written for mothers, because if you have carried a pregnancy, the abdomen — the injection site most people default to — is the part of you most likely to be marked.

First, the easier question

A GLP-1 does not appear to create stretch marks, and the framing of the question is slightly backwards.

Stretch marks are stretch injuries. The dermatologic literature describes striae distensae as linear lesions of atrophic skin, characterized histologically by thinning of the epidermis, loss of the ridge structure at the junction between the skin's layers, and altered connective-tissue architecture. Hormonal excess, mechanical stress and genetic predisposition are all associated with them — although a 2021 review from Stanford's plastic surgery division states plainly that their exact pathogenesis remains unknown¹.

Every one of those associated causes is about tissue being stretched or hormonally destabilized. Losing weight quickly is the opposite mechanical event.

What rapid weight loss does do is make marks you already have more noticeable. As the fat underneath them decreases, the skin covering it has less to sit against. Striae that were smooth and stretched flat over a fuller abdomen become more visible, more textured, sometimes more crepey at the edges — not because the drug created them, but because it removed what was holding them taut.

That is the same underlying change discussed on the loose skin after GLP-1 weight loss page, and if what you are noticing is texture rather than new lines, that page is the more useful one.

There is a genuine exception worth naming: marks can form during any period of rapid gain, including a regain after stopping treatment. If you have gone through a loss-and-regain cycle, new striae from the regain are plausible. The drug did not put them there; the direction of the weight change did.

The question nobody has answered

Now the practical one. Can you inject into a stretch mark?

Here is the honest state of the evidence: there is no published study of injecting a GLP-1 receptor agonist into striae, and no absorption data for it. Not a small study, not a poor one — none. Anyone giving you a confident percentage is inventing it.

What can be done is reason carefully from anatomy, and label that reasoning honestly as reasoning.

Start with what the label actually requires. These are subcutaneous injections. The Wegovy label lists three acceptable sites — the abdomen, the thigh and the upper arm — and instructs rotating sites with each dose. Notably, it also reports that similar drug exposure was achieved across all three: the pharmacokinetics section states that comparable exposure was reached with subcutaneous administration in the abdomen, thigh, or upper arm. The site is not a dosing variable in the way people fear.

Now the anatomy of a stretch mark. The changes that define striae are in the epidermis and dermis — the surface and the layer immediately beneath it. That is thinned, structurally altered skin. But a subcutaneous injection is not aiming at the dermis. It is aiming at the fat layer below it, and that fat is not what striae are made of.

So the reasoning runs: the tissue changed by a stretch mark is not the tissue the drug is being delivered into. That argues the marks are unlikely to matter much for absorption.

And the reasoning's own weakness, stated: striae are atrophic, meaning thinner. Over a thin mark, the same needle length travels through less skin before it reaches fat — or, in an area where fat is now much reduced, potentially past it. Nobody has measured this. It is a plausible concern and it is not a documented one.

The practical version most nurses and diabetes educators land on, and which is consistent with all of the above: there is no strong reason to avoid a stretch mark, and easier reasons to avoid other things.

What to actually avoid, which is not stretch marks

The injection-site rules that do have an evidence base behind them come from decades of insulin practice, not from GLP-1 trials — but the tissue principle transfers, and it points somewhere other than striae.

Avoid scar tissue proper. A surgical scar — a cesarean scar most of all, for this readership — is dense fibrous tissue with disrupted blood supply. That is a genuinely different situation from a stretch mark, and it is the one with a real mechanistic argument for unreliable absorption. Injecting near a cesarean scar is worth keeping a couple of inches clear of.

Avoid repeatedly using one small patch. This is the actual documented failure mode in injectable therapy — repeated injection into the same small area produces thickened, lumpy tissue, and drug absorbed from it is less predictable. It is also exactly what happens when someone finds "the spot that does not hurt" and returns to it every week.

Avoid skin that is broken, inflamed, bruised or tender.

Notice that stretch marks are on none of those lists. Rotation solves the real problem, and rotation is already the label's instruction.

If it is the appearance you mind

Say this part plainly rather than gesturing at it: for many women the stretch-mark question is not about pharmacology at all. It is about looking down at a body that is changing quickly and seeing something that has bothered you since a pregnancy become more visible rather than less, at the exact moment you were promised improvement.

The evidence on treating striae is genuinely disappointing and it is fairer to say so than to sell hope. The 2021 review's conclusion is that despite a multitude of options, no single treatment has yet proven effective¹. A 2022 review of therapeutic modalities surveys the field — topical agents, lasers, microneedling, radiofrequency — and reaches a similar place: some approaches show promise for some mark types, and none is reliably effective².

Two things that are worth knowing anyway:

Age of the mark matters more than any product. Red or purple striae are newer and inflamed, and they respond better to intervention than old white ones, which are settled scar tissue. If treatment is something you want to pursue, newer marks are the better target.

Nothing you apply will out-perform what time does. Striae fade on their own, slowly, over years. Most before-and-after marketing in this category is photographing that.

The summary

The drug is not making new stretch marks; losing the volume underneath them is making the old ones easier to see.

Whether you can inject into one has never been studied, and the anatomy suggests it does not much matter, because subcutaneous injection targets the fat beneath the skin rather than the altered skin itself. Rotate properly, stay clear of a cesarean scar, and stop returning to the same comfortable square inch.

And if the honest answer to your real question is that the marks bother you — that is not a medical problem to be solved and it is not vanity either. It is a reasonable response to watching your body change faster than your feelings about it can keep up.